Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANDU PHARMA vs SHUKRA PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SANDU PHARMA SHUKRA PHARMA SANDU PHARMA/
SHUKRA PHARMA
 
P/E (TTM) x 48.8 19.3 253.0% View Chart
P/BV x 1.4 14.1 10.0% View Chart
Dividend Yield % 1.3 0.2 853.5%  

Financials

 SANDU PHARMA   SHUKRA PHARMA
EQUITY SHARE DATA
    SANDU PHARMA
Mar-23
SHUKRA PHARMA
Mar-23
SANDU PHARMA/
SHUKRA PHARMA
5-Yr Chart
Click to enlarge
High Rs8689 97.0%   
Low Rs5011 451.9%   
Sales per share (Unadj.) Rs67.653.7 126.0%  
Earnings per share (Unadj.) Rs1.64.0 39.2%  
Cash flow per share (Unadj.) Rs2.15.7 37.0%  
Dividends per share (Unadj.) Rs0.750.50 150.0%  
Avg Dividend yield %1.11.0 109.9%  
Book value per share (Unadj.) Rs40.623.1 176.0%  
Shares outstanding (eoy) m9.6610.96 88.1%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.00.9 108.3%   
Avg P/E ratio x43.312.4 348.7%  
P/CF ratio (eoy) x32.38.8 368.8%  
Price / Book Value ratio x1.72.2 77.6%  
Dividend payout %47.612.4 383.1%   
Avg Mkt Cap Rs m658547 120.3%   
No. of employees `000NANA-   
Total wages/salary Rs m11144 251.5%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m653588 111.1%  
Other income Rs m312 27.3%   
Total revenues Rs m657600 109.4%   
Gross profit Rs m2554 46.4%  
Depreciation Rs m518 28.1%   
Interest Rs m13 28.5%   
Profit before tax Rs m2244 49.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m70 1,988.6%   
Profit after tax Rs m1544 34.5%  
Gross profit margin %3.89.1 41.7%  
Effective tax rate %31.40.8 3,962.8%   
Net profit margin %2.37.5 31.1%  
BALANCE SHEET DATA
Current assets Rs m255531 48.1%   
Current liabilities Rs m139425 32.7%   
Net working cap to sales %17.818.0 99.4%  
Current ratio x1.81.2 147.4%  
Inventory Days Days650-  
Debtors Days Days2681,873 14.3%  
Net fixed assets Rs m286219 130.7%   
Share capital Rs m9739 246.8%   
"Free" reserves Rs m296214 138.3%   
Net worth Rs m392253 155.1%   
Long term debt Rs m038 0.0%   
Total assets Rs m542750 72.3%  
Interest coverage x28.716.8 170.8%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x1.20.8 153.7%   
Return on assets %3.06.3 47.2%  
Return on equity %3.917.4 22.2%  
Return on capital %5.916.2 36.0%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m00-   
Fx outflow Rs m00-   
Net fx Rs m00-   
CASH FLOW
From Operations Rs m232 7.0%  
From Investments Rs m5-44 -12.1%  
From Financial Activity Rs m649 11.7%  
Net Cashflow Rs m1337 36.3%  

Share Holding

Indian Promoters % 42.9 51.0 84.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 0.1 9.1%  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 57.1 49.0 116.4%  
Shareholders   10,021 10,963 91.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SANDU PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on SANDU PHARMA vs RELISH PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

SANDU PHARMA vs RELISH PHARMA Share Price Performance

Period SANDU PHARMA RELISH PHARMA S&P BSE HEALTHCARE
1-Day -0.45% -2.00% 1.18%
1-Month -15.08% 18.32% -0.75%
1-Year 9.73% 528.10% 61.82%
3-Year CAGR 19.30% 229.50% 18.16%
5-Year CAGR 21.14% 114.18% 19.79%

* Compound Annual Growth Rate

Here are more details on the SANDU PHARMA share price and the RELISH PHARMA share price.

Moving on to shareholding structures...

The promoters of SANDU PHARMA hold a 42.9% stake in the company. In case of RELISH PHARMA the stake stands at 51.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of SANDU PHARMA and the shareholding pattern of RELISH PHARMA.

Finally, a word on dividends...

In the most recent financial year, SANDU PHARMA paid a dividend of Rs 0.8 per share. This amounted to a Dividend Payout ratio of 47.6%.

RELISH PHARMA paid Rs 0.5, and its dividend payout ratio stood at 12.4%.

You may visit here to review the dividend history of SANDU PHARMA, and the dividend history of RELISH PHARMA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.